International Journal of Cancer

• 

  Publication Venue For

  • Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)..  146:2394-2405. 2020
  • Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States..  145:143-153. 2019
  • Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology..  140:1447-1456. 2017
  • A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma..  140:480-484. 2017
  • Polymorphisms in DNA repair genes, traffic-related polycyclic aromatic hydrocarbon exposure and breast cancer incidence..  139:310-321. 2016
  • Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy..  137:2454-2461. 2015
  • A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery..  136:1976-1984. 2015
  • Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis..  136:E751-E759. 2015
  • Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase..  129:553-564. 2011
  • Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk..  126:2509. 2010
  • Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening.  126:469-473. 2010
  • Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis..  121:2596-2605. 2007
  • DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage..  121:1724-1728. 2007
  • Cancer risk in women prenatally exposed to diethylstilbestrol..  121:356-360. 2007
  • Defective antitumor responses in CX3CR1-deficient mice..  121:316-322. 2007
  • Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse..  120:2339-2343. 2007
  • Effects of base excision repair gene polymorphisms on pancreatic cancer survival..  120:1748-1754. 2007
  • Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism..  120:1005-1012. 2007
  • In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer..  120:906-917. 2007
  • 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer.  121:2547-2555. 2007
  • Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women..  119:2173-2178. 2006
  • Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients..  119:1455-1461. 2006
  • Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population..  118:2554-2558. 2006
  • Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH..  118:1159-1164. 2006
  • Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population..  118:1275-1278. 2006
  • Corroboration of a familial chordoma locus on chromosome 7q and evidence of genetic heterogeneity using single nucleotide polymorphisms (SNPs)..  116:487-491. 2005
  • DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population..  115:478-483. 2005
  • Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis..  115:131-136. 2005
  • Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population..  114:455-460. 2005
  • Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer..  113:1022-1025. 2005
  • Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers..  112:754-759. 2004
  • Multiple mechanisms of action of ZR2002 in human breast cancer cells: a novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA..  112:484-491. 2004
  • Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum.  112:135-142. 2004
  • Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice..  111:475-479. 2004
  • NF-κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells.  108:181-188. 2004
  • Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2..  107:603-611. 2003
  • Smoking, DNA repair capacity and risk of nonsmall cell lung cancer..  107:84-88. 2003
  • Meta-analysis of social inequality and the risk of cervical cancer.  105:687-691. 2003
  • Health-related quality of life of children with acute lymphoblastic leukaemia: comparisons and correlations between parent and clinician reports..  103:514-518. 2003
  • The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice..  103:300-305. 2003
  • Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma..  102:338-342. 2002
  • Prevalence of human papillomavirus in cervical cancer: A multicenter study in China.  100:327-331. 2002
  • A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis..  99:869-872. 2002
  • Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma..  98:419-426. 2002
  • Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors..  97:713-715. 2002
  • Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era..  96:363-371. 2001
  • Superantigen enhanced protection against a weak tumor-specific melanoma antigen: implications for prophylactic vaccination against cancer..  94:834-841. 2001
  • Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study..  95:332-336. 2001
  • Prognostic significance of BAG-1 expression in nonsmall cell lung cancer.  95:317-322. 2001
  • Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization..  96:243-252. 2001
  • In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck..  93:436-440. 2001
  • Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness..  93:236-242. 2001
  • Clinical staging of prostate cancer: reproducibility and clarification of issues..  96:198-209. 2001
  • Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes..  92:322-328. 2001
  • Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate specific antigen..  96:91-93. 2001
  • Non-human to human organ transplantation: its biologic basis and a potential role for radiation therapy..  96:76-89. 2001
  • Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier..  91:334-339. 2001
  • Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas..  95:34-38. 2001
  • Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer.  95:29-33. 2001
  • Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv..  88:962-969. 2000
  • Effects of radiation on the levels of MMP-2, MMP-9 and TIMP-1 during morphogenic glial-endothelial cell interactions..  88:766-771. 2000
  • In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215..  88:652-657. 2000
  • Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population..  88:601-606. 2000
  • Review of methods used to study oxygen transport at the microcirculatory level..  90:237-255. 2000
  • p53-dependent induction of heat shock protein 27 (HSP27) expression..  88:191-194. 2000
  • Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial..  87:601-605. 2000
  • Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes..  86:818-826. 2000
  • ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers..  86:690-694. 2000
  • Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity..  85:376-383. 2000
  • Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity..  83:532-540. 1999
  • Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238..  82:592-598. 1999
  • Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA..  82:121-124. 1999
  • Allelic loss on chromosome 6Q in primary prostate cancer..  84:331-335. 1999
  • Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck..  84:220-224. 1999
  • Mutational analysis of thePTEN gene in gliomas: Molecular and pathological correlations.  84:150-154. 1999
  • Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1_27-35 peptide: Implications for peptide vaccines.  83:326-334. 1999
  • Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase..  78:46-52. 1998
  • IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential..  77:138-145. 1998
  • Effect of parity and age at delivery on breast cancer risk in Slovenian women aged 25-54 years..  73:1-9. 1997
  • Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector..  71:377-382. 1997
  • Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts..  70:706-715. 1997
  • Radio-induced modulation of transforming growth factor beta1 sensitivity in a p53 wild-type human colorectal-cancer cell line..  68:126-131. 1996
  • Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA..  67:898-902. 1996
  • Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin..  67:695-701. 1996
  • Incidence of germ-linep53 mutations in patients with gliomas.  64:383-387. 1995
  • CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines..  63:226-230. 1995
  • TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract..  64:229-233. 1995
  • Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies..  58:161-167. 1994
  • Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent..  57:908-913. 1994
  • Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma..  56:552-559. 1994
  • Induction of tissue-type plasminogen activator and 72-kDa type-IV collagenase by ionizing radiation in rat astrocytes..  56:214-218. 1994
  • Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells..  53:409-417. 1993
  • Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185..  53:401-408. 1993
  • Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma..  52:934-940. 1992
  • Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.  52:682-687. 1992
  • Effect of IL-1 on experimental bone/bone-marrow metastases..  52:802-807. 1992
  • Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxicity..  52:609-618. 1992
  • Immunoreactivity, pharmacokinetics and bone marrow dosimetry of intrathecal radioimmunoconjugates..  52:38-43. 1992
  • A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines..  51:772-779. 1992
  • Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction..  50:694-701. 1992
  • Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines..  50:659-664. 1992
  • Glutathione and cellular response of ACNU-resistant rat glioma sublines to drugs and radiation.  48:861-865. 1991
  • Characterization of a new model of human prostatic cancer: the multicellular tumor spheroid..  46:238-244. 1990
  • Polyamine-directed preferential nutritional repletion of normal tissues in tumor-bearing hosts..  42:744-747. 1988
  • The relationship of collagenolytic activity to stage of human colorectal carcinoma..  40:24-31. 1987
  • EL-4 metastases in spleen and bone marrow suppress the NK activity generated in these organs..  39:118-125. 1987
  • The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA..  39:25-29. 1987
  • Red blood cell polyamine levels and host toxicity during continuous alpha-difluoromethylornithine infusion..  38:245-249. 1986
  • Antibody-dependent cellular cytotoxicity and disease course in North American patients with nasopharyngeal carcinoma: a prospective study..  33:777-782. 1984
  • Nasopharyngeal carcinoma in american children: Epstein-Barr virus-specific antibody titers and prognosis.  29:209-212. 1982
  • Metabolism of benzo[a]pyrene by cultured tracheobronchial tissues from mice, rats, hamsters, bovines and humans..  25:293-300. 1980
  • Isolation of a human prostate carcinoma cell line (DU 145)..  21:274-281. 1978
  • Platelet—tumor-cell interactions in mice. The role of platelets in the spread of malignant disease.  11:704-718. 1973
  • Ribosomal RNA in avian leukosis virus particles..  7:535-546. 1971
  • IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas (International Journal of Cancer (2009) 125, (2673-2678)).  126:799. 2010
  • Role of alpha 1G T-type calcium channels in retinoblastoma cell differentiation and proliferation 2002